A Study of SII Yellow Fever Vaccine to Compare Safety and Immunogenicity With STAMARIL

NCT05421611 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1824

Enrollment

INDUSTRY

Sponsor class

Conditions

Yellow Fever

Interventions

BIOLOGICAL: STAMARIL
BIOLOGICAL: SII-YFV

Sponsor

Serum Institute of India Pvt. Ltd.